Leukemia M3 is relatively not a high-risk type, because it is one of the better prognosis among all acute leukemias, but there are still some matters that need attention.
1. The early stage of the disease is dangerous, often combined with coagulation disorders, bleeding tendency is obvious, some patients can be due to intracranial hemorrhage, which is life-threatening, so in the early stage of the disease need to consult the doctor in a timely manner to improve the survival rate.
2. The treatment is divided into two stages: induction of remission and consolidation therapy, commonly used retinoic acid plus anthracyclines, most patients can achieve complete remission after induction of remission therapy, and then enter the consolidation therapy, the efficacy of the patients without transplantation can achieve clinical remission.
In conclusion, leukemia M3 is one of the acute leukemias with a better prognosis. Under the guidance of hematologists and regular treatment, long-term disease-free survival can be achieved.